Highlights
AMEX: NBY       Novabay Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
0.511   -0.029 (5.37%)  0.50 - 0.57  268,600

Overview

 
Avg Volume (4 weeks):382,965
4 Weeks Range:0.48 - 0.79
4 Weeks Price Volatility (%):
10.00%
52 Weeks Range:0.229 - 4.04
52 Weeks Price Volatility (%):
7.40%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

NovaBay Pharmaceuticals Inc is a biopharmaceutical company. The company develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). NovaBay develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.

  Be the first to like this.
 


 

4308  3684  701  236 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.01 
 EEM 43.13+0.34 
 AMD 38.56+0.21 
 SPY 311.79+2.24 
 ACB 2.73-0.56 
 AIHS 1.07+0.65 
 AMRN 24.02+2.53 
 FCEL 0.825-0.064 
 TVIX 7.12-0.71 
 UBER 26.79+0.80 
Partners & Brokers